PureTech Health PLC (OTCPK:PTCHF)

$ 2 0.01 (0.5%) Market Cap: 458.92 Mil Enterprise Value: -23.08 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 48/100

Half Year 2024 PureTech Health PLC Earnings Call Transcript
Aug 28, 2024

$2.2

Earnings
PureTech Health PLC at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Half Year 2023 PureTech Health PLC Earnings Call Transcript
Aug 29, 2023

$2.36

Earnings
PureTech Health PLC at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Full Year 2022 PureTech Health PLC Earnings Call Transcript
Apr 28, 2023

$2.56 (-2.66%)

Earnings
PureTech Health PLC at Barclays Global Healthcare Conference Transcript
Mar 14, 2023
PureTech Health PLC at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
PureTech Health PLC Medical Research Update Transcript
Dec 07, 2022
PureTech Health PLC at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 30, 2022
PureTech Health PLC at Piper Sandler Healthcare Conference Transcript
Nov 29, 2022
PureTech Health PLC at Jefferies London Healthcare Conference Transcript
Nov 16, 2022
PureTech Health PLC at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022
PureTech Health PLC at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022
Half Year 2022 PureTech Health PLC Earnings Call Transcript
Aug 25, 2022

$2.95

Earnings
PureTech Health PLC at UBS Global Healthcare Conference Transcript
May 24, 2022
Full Year 2021 PureTech Health PLC Earnings Call Transcript
Apr 26, 2022

$2.49

Earnings
Akili Interactive Labs Inc To Become Publicly Traded Through Combination With Social Capital Suvretta Holdings Corp I Call Transcript
Jan 26, 2022
PureTech Health PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Half Year 2021 PureTech Health PLC Earnings Call Transcript
Aug 24, 2021

$4.61 (+4.30%)

Earnings
Gelesis Inc To Discuss Definitive Business Combination Agreement With PureTech Health PLC And Capstar Special Purpose Acquisition Corp Call Transcript
Jul 19, 2021
Full Year 2020 PureTech Health PLC Earnings Call Transcript
Apr 15, 2021

$5.71 (+1.33%)

Earnings
PureTech Health PLC at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021
PureTech Health PLC at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 26, 2021
PureTech Health PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021
PureTech Health PLC R&D Day Transcript
Dec 11, 2020
PureTech Health PLC at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 12, 2020
Half Year 2020 PureTech Health PLC Earnings Call Transcript
Aug 27, 2020

$3.65 (-1.75%)

Earnings

PureTech Health PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 03:50PM GMT

Release Date Price: $5.3

Transcript

Unidentified Analyst

Good morning, everyone, and welcome to the 39th Annual JPMorgan Healthcare Conference. My name is [Vedder Schader]. I'm a Vice President in our health care investment banking team. And it's my pleasure today to introduce you to our next presenting company, that is PureTech. And we have our next presenter, Daphne Zohar, the founder and CEO of PureTech.

Before we start, though, I'd just like to mention that we'll -- after the prepared remarks, we'll have about 10 to 15 minutes of Q&A, and you'll be able to submit a question through the link on the website, the blue Submit A Question button.

And with that, I'll hand it over to Daphne.

Daphne Zohar

PureTech Health plc - Founder, CEO & Executive Director

Thank you, [Vedder], and to the JPMorgan team for inviting us to present, and welcome to everyone who is listening and watching via webcast.

We have a very unique story to tell at PureTech. And importantly, we have a highly promising wholly-owned therapeutic development pipeline that we're going to dig into during

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.